Gentian innovates diagnostic efficiency by leveraging proprietary, disruptive, diagnostic technologi
Location: Norway, Moss
Phone: +47 993 39 905
Investors 1
| Date | Name | Website |
| - | BioHealth ... | biohealthi... |
Mentions in press and media 12
| Date | Title | Description |
| 03.02.2022 | Webinar: «Calprotectin, a new routine inflammation biomarker » | Webinar with Dr Camille Chenevier-Gobeaux from Assistance publique - Hôpitaux de Paris Time : February 8th at 12:00-13:00 (CET) Calprotectin is a novel inflammation biomarker with diagnostic value in various infectious and inflammatory cond... |
| 21.12.2021 | Gentian Diagnostics : COVID-19 and calprotectin's clinical value | Calprotectin as a valuable prognostic marker in care of COVID-19 patients The rising numbers of SARS-CoV-2 infections during the recent weeks are again pushing the health systems to their limits. Early identification of infected patients wh... |
| 22.11.2021 | Gentian Diagnostics : Cystatin C at IFCC EuroMedLab 2021 | Meet us at EuroMedLab - Booth #201 Gentian Diagnostics looks forward to exhibit at IFCC EuroMedLab 2021promoting our turbidimetric cystatin C immunoassay. Visit us at booth #201 to learn more. Cystatin C - Superior Kidney Marker1 More than ... |
| 16.11.2021 | FAQ: Why is the cystatin C test perceived to be costly? | In this segment we are answering questions our Product Manager for cystatin C and our Product Specialist in the US receive about cystatin C and our cystatin C immunoassay at exhibitions, conferences, and client meetings. Today's question is... |
| 05.11.2021 | New study results confirm calprotectin's role in risk stratification & estimation of disease severity in COVID-19 | New study results from two COVID-19 studies have recently been published. The CASCADE trail study in collaboration with Charité - Universitätsmedizin Berlin and Labor Berlin has published first results in a poster at the European Society fo... |
| 25.06.2021 | Gentian Diagnostics : was today listed on the Oslo Stock Exchange | 'We made a promise to our shareholders when we were listed on Euronext Growth that we would aim for the main list when the company had matured. I'm pleased that we now have reached this milestone, and that we have access to a high-quality i... |
| 25.05.2021 | GENTIAN DIAGNOSTICS AS FAQ: How is calprotectin useful to monitor treatment response in rheumatoid arthritis? | Calprotectin levels correlate with disease activity in rheumatoid arthritis (RA)1-3and can therefore be used in monitoring of disease activity, treatment response and relapse4-6. Calprotectin has been reported as valuable tool to monitor pa... |
| 20.05.2021 | GENTIAN DIAGNOSTICS AS FAQ: How is calprotectin useful in clinical assessment of rheumatoid arthritis? | Calprotectin, a biomarker for neutrophil activation and inflammation, has been shown to have clinical diagnostic value in assessment of disease activity in rheumatoid arthritis (RA), including the potential to monitor the treatment response... |
| 28.04.2021 | FAQ: What type of assay is the Gentian Calprotectin Immunoassay GCAL®? | What type of assay is GCAL®? In our Frequently Asked Questions about calprotectin series we will answer questions we often receive about plasma and serum calprotectin and the Gentian Calprotectin Immunoassay GCAL®. If you have any additiona... |
| 08.04.2021 | Gentian Diagnostics : Cystatin C guided medication dosing | Assessment of kidney function for ensuring correct drug dosage The kidneys are an important site of elimination for most medications and their metabolites. For this reason, an accurate assessment of kidney function is critical for ensuring ... |
Show more